Myeloperoxidase-antineutrophil cytoplasmic antibody-associated diffuse alveolar hemorrhage caused by denosumab
Denosumab is a bone anti-resorptive drug, commonly used for treating osteoporosis. Pulmonary involvement has rarely been reported as a possible serious adverse effect of this medication. Herein, we report the case of a 67-year-old woman who presented with non-massive hemoptysis, anemia, and extensiv...
Saved in:
Main Authors: | Akarawut Kasemchaiyanun, Viboon Boonsarngsuk, Somprasong Liamsombut, Pimpin Incharoen, Warawut Sukkasem |
---|---|
Other Authors: | Ramathibodi Hospital |
Format: | Article |
Published: |
2022
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/74940 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Myeloperoxidase-antineutrophil cytoplasmic antibody-associated diffuse alveolar hemorrhage caused by denosumab
by: Kasemchaiyanun A.
Published: (2023) -
Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
by: Kimberly A. Morishita, et al.
Published: (2018) -
Propylthiouracil-induced sensorineural hearing loss associated with antineutrophil cytoplasmic antibodies
by: Sriurai Thamprajamchit, et al.
Published: (2018) -
Antineutrophil cytoplasmic antibody (ANCA) and rapidly progressive crescentic glomerulonephritis in Thai population
by: Vasant Sumethkul, et al.
Published: (2018) -
Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset graves' disease
by: Ouyporn Panamonta, et al.
Published: (2018)